Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Summit Therapeutics set to begin HARMONi trial of Ivonescimab in EGFR-mutant lung cancer Summit Therapeutics Inc. has announced a significant milestone in its oncology development efforts, completing patient enrollment for the… byPallavi MadhirajuOctober 6, 2024